395 related articles for article (PubMed ID: 23550857)
1. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
Al-Sawaf A; El-Mazny A; Shohayeb A
J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857
[TBL] [Abstract][Full Text] [Related]
2. Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial.
Bellad MB; Tara D; Ganachari MS; Mallapur MD; Goudar SS; Kodkany BS; Sloan NL; Derman R
BJOG; 2012 Jul; 119(8):975-82; discussion 982-6. PubMed ID: 22703421
[TBL] [Abstract][Full Text] [Related]
3. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
Chaudhuri P; Biswas J; Mandal A
Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
[TBL] [Abstract][Full Text] [Related]
4. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
[TBL] [Abstract][Full Text] [Related]
6. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
[TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour.
Walley RL; Wilson JB; Crane JM; Matthews K; Sawyer E; Hutchens D
BJOG; 2000 Sep; 107(9):1111-5. PubMed ID: 11002954
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage.
Priya GP; Veena P; Chaturvedula L; Subitha L
Arch Gynecol Obstet; 2015 Dec; 292(6):1231-7. PubMed ID: 25990482
[TBL] [Abstract][Full Text] [Related]
9. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
Elgafor el Sharkwy IA
Arch Gynecol Obstet; 2013 Dec; 288(6):1231-6. PubMed ID: 23689739
[TBL] [Abstract][Full Text] [Related]
10. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.
Lam H; Tang OS; Lee CP; Ho PC
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):647-50. PubMed ID: 15225189
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor.
Vaid A; Dadhwal V; Mittal S; Deka D; Misra R; Sharma JB; Vimla N
Arch Gynecol Obstet; 2009 Dec; 280(6):893-7. PubMed ID: 19277690
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour.
Oboro VO; Tabowei TO
J Obstet Gynaecol; 2003 Jan; 23(1):13-6. PubMed ID: 12623474
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
Ugwu IA; Oluwasola TA; Enabor OO; Anayochukwu-Ugwu NN; Adeyemi AB; Olayemi OO
Int J Gynaecol Obstet; 2016 May; 133(2):173-7. PubMed ID: 26892695
[TBL] [Abstract][Full Text] [Related]
15. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
[TBL] [Abstract][Full Text] [Related]
16. Sublingual misoprostol to decrease blood loss after caesarean delivery: a randomised controlled trial.
Ugwu IA; Enabor OO; Adeyemi AB; Lawal OO; Oladokun A; Olayemi O
J Obstet Gynaecol; 2014 Jul; 34(5):407-11. PubMed ID: 24724983
[TBL] [Abstract][Full Text] [Related]
17. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial.
Høj L; Cardoso P; Nielsen BB; Hvidman L; Nielsen J; Aaby P
BMJ; 2005 Oct; 331(7519):723. PubMed ID: 16195287
[TBL] [Abstract][Full Text] [Related]
18. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour.
Afolabi EO; Kuti O; Orji EO; Ogunniyi SO
Singapore Med J; 2010 Mar; 51(3):207-11. PubMed ID: 20428741
[TBL] [Abstract][Full Text] [Related]
19. Sublingual misoprostol for the prevention of postpartum hemorrhage.
Al-Harazi AH; Frass KA
Saudi Med J; 2009 Jul; 30(7):912-6. PubMed ID: 19618006
[TBL] [Abstract][Full Text] [Related]
20. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
Musa AO; Ijaiya MA; Saidu R; Aboyeji AP; Jimoh AA; Adesina KT; Abdul IF
Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
